Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
10.13B | 10.46B | 12.49B | 8.70B | 6.83B | 6.80B | Gross Profit |
4.66B | 4.35B | 1.93B | 1.74B | 2.10B | 1.82B | EBIT |
2.91B | 2.61B | 1.11B | 1.24B | 900.00M | 769.80M | EBITDA |
3.87B | 3.67B | 831.80M | 4.14B | 1.46B | 1.91B | Net Income Common Stockholders |
2.00B | 1.71B | -158.00M | 3.03B | 2.28B | 167.90M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
890.80M | 1.04B | 1.21B | 1.13B | 1.60B | 421.00M | Total Assets |
28.58B | 28.27B | 27.14B | 25.76B | 21.59B | 21.03B | Total Debt |
9.58B | 9.13B | 10.94B | 10.12B | 10.88B | 11.34B | Net Debt |
8.69B | 8.10B | 9.73B | 8.98B | 9.28B | 10.92B | Total Liabilities |
16.51B | 16.47B | 17.91B | 17.64B | 16.38B | 17.28B | Stockholders Equity |
11.29B | 11.05B | 8.58B | 8.08B | 5.21B | 3.75B |
Cash Flow | Free Cash Flow | ||||
646.60M | 1.35B | -360.90M | 121.40M | 593.30M | 42.80M | Operating Cash Flow |
2.91B | 3.86B | 1.46B | 1.58B | 1.77B | 1.25B | Investing Cash Flow |
-3.17B | -2.86B | -2.96B | -744.90M | 443.70M | -1.01B | Financing Cash Flow |
247.80M | -857.60M | 1.35B | -1.38B | -778.70M | -603.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $6.39B | 4.41 | 26.38% | 72.58% | -4.14% | 13.02% | |
78 Outperform | $6.54B | 12.98 | 9.22% | 3.40% | -7.02% | 17.33% | |
72 Outperform | $27.10B | 17.70 | 12.27% | 2.17% | -9.86% | 240.30% | |
72 Outperform | $48.30B | 16.30 | 9.76% | 3.48% | -0.39% | 0.75% | |
64 Neutral | $8.53B | 10.30 | 4.25% | 5.88% | 4.06% | -12.76% | |
64 Neutral | $21.20B | 2,867.59 | 0.47% | 5.29% | 12.40% | -108.27% | |
55 Neutral | $7.41B | 5.68 | 29.79% | 6.76% | -3.22% | 141.11% |